Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1697 clinical trials
None
LMBA02 Protocol for Patients With a Burkitt Lymphoma

EFS than the LMB chemotherapy scheme alone in patients older than 18 years with Burkitt lymphoma or ALL 3.

rituximab
  • 11 views
  • 07 Nov, 2020
  • 1 location
None
PEG-ASP Etoposide and Gemcitabine for Natural Killer/T Lymphoma

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive form of non-Hodgkin's lymphoma and shows extremely poor survival. This prospective pilot study to evaluate the efficacy and

  • 0 views
  • 29 Jan, 2021
  • 2 locations
None
PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive form of non-Hodgkin's lymphoma and shows extremely poor survival. This prospective pilot study to evaluate the efficacy and

  • 1 views
  • 22 Mar, 2021
  • 1 location
None
The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma

This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) infusion to patients with lymphoid malignancies.

  • 0 views
  • 24 Sep, 2021
  • 5 locations
None
Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell Lymphoma

Natural killer/T-cell lymphoma (NKTCL) patients with relapsed/refractory disease had very poor outcome. Anti-PD-1 antibody showed promising results in response, but but the complete remission

  • 0 views
  • 03 Oct, 2021
  • 1 location
None
Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma

with high-risk follicular lymphoma with either partial or complete response to R-CHOP induction chemotherapy

r-chop
ibritumomab tiuxetan
zevalin
  • 19 views
  • 07 Nov, 2020
  • 1 location
None
Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Phase II study for treatment of patients with relapsed or primary refractory aggressive B- cell NHL and anthracycline chemotherapy pretreatment, who received or did not qualify for autologous stem cell transplantation.

cell transplantation
bendamustine
rituximab
anthracyclines
salvage therapy
  • 16 views
  • 07 Nov, 2020
  • 1 location
None
Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's Lymphoma

High-dose chemotherapy and autologous stem-cell transplantation have an established role in the treatment of aggressive Non-Hodgkin's lymphoma (NHL) when refractory to first line

lymphoma cell count
zevalin
rituximab
aggressive non-hodgkin's lymphoma
hodgkin's disease
  • 26 views
  • 07 Nov, 2020
  • 1 location
None
Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

The purpose of this study is to investigate the ability to combine a radioactive medication directly targeted against lymphoma cells with the immune effects of an allogeneic blood stem

mantle cell lymphoma
lymphoma cell count
fludarabine
zevalin
cyclophosphamide
  • 7 views
  • 07 Nov, 2020
  • 1 location
None
Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma Nasal Type

diagnosed advanced extranodal natural killer/T-cell lymphoma, nasal type (ENKTL)

  • 0 views
  • 23 Jan, 2021
  • 1 location